Overview
Provide strategic guidance and scientific recommendations in the Toxicology space for a fortune 200 company with some of the most iconic brands! Have a degree in Toxicology or related field? Have experience in nonclinical studies and ready to apply your expertise to solve real-world toxicology challenges? If so, we want to speak with you!
We are looking for a Principal Nonclinical Toxicologist to join our Biological Sciences Insights (BSI) group in Richmond, VA, or we are open to remote work arrangements.
The selected candidate will use their scientific expertise in strategic growth and application of our nonclinical toxicology program, supporting the development and marketing of the company's portfolio of reduced-risk tobacco and nicotine products.
What you will be doing:
Provide strategic guidance and scientific recommendations in health risk evaluations using regulatory and mechanistic toxicology tools and applications
Identify gaps and implement capability expansion in nonclinical testing with external testing partners. Test materials are diverse, ranging from individual chemicals to mixtures, and from oral to inhalable tobacco and nicotine products
Lead and work proactively on individual and cross-functional projects, using both standardized and novel New Alternative Methods (NAMs) to expand predictive toxicology capability
Serve as Study Sponsor on externally executed studies; design, monitor, interpret the results and reporting for internal communication and regulatory submissions
Identify, screen, and qualify external CROs for regulatory and foundational studies; Manage projects to proactively meet timeline and budget, and ensure Quality and Data Integrity in both GLP and non-GLP studies
Represent the company via regular presentations at toxicology or tobacco-related conferences and peer-review publications
Keep abreast of toxicology-related fields and bring insight to build internal capability, and engage strategically in the scientific community
Occasional travel (10-20%) to CROs such as for lab selection, inspection, or study monitoring
What we want you to have:
Bachelor's degree required with 10+ years of experience in Toxicology or related field. Advanced degree or DABT certification is preferred, with 5+ years of post-graduate experience in related field
Experience (e.g., study director, study monitor) in conducting nonclinical studies using various test systems (e.g., in vitro - cells to 3D tissues; in vivo - rodents with oral or inhalation exposures)
Proven experience in designing and implementing mechanistic toxicology studies (e.g., systems toxicology - omics and pathway analysis; disease biomarkers) are highly desirable
Experience in project management with attention to detail and analytical reasoning skills
Ability to communication with a diverse audience (technical and non-technical).
Ability to work independently and multi-task under deadlines in a fast-paced environment
A great teammate and mentor with effective interpersonal skills; seeks feedback to implement
In addition to the growth opportunity to expand your expertise toward business objectives, we offer an excellent compensation package including a competitive base salary, comprehensive health/vision/dental insurance, participation in our deferred profit sharing and incentive compensation programs as well as a relocation assistance package.Company OverviewAltria has a leading portfolio of tobacco products for U.S. tobacco consumers age 21+. Altria's Vision through 2030 is to responsibly lead the transition of adult smokers to a non-combustible future. Altria is Moving Beyond Smoking, leading the way in moving adult smokers away from cigarettes by taking action to transition millions to potentially less harmful choices - believing it is a substantial opportunity for adult tobacco consumers, Altria's businesses and society. Altria's wholly owned subsidiaries include the most profitable tobacco companies in their categories: Philip Morris USA Inc. (PM USA), U.S. Smokeless Tobacco Company LLC (USSTC), and John Middleton Co. (Middleton). Altria's smoke-free portfolio includes Helix Innovations LLC (Helix), the maker of on! oral nicotine pouches, exclusive U.S. commercialization rights to the IQOS Tobacco Heating System* and Marlboro HeatSticks*, and an equity investment in JUUL Labs, Inc. (JUUL). Altria also owns equity investments in Anheuser-Busch InBev SA/NV (ABI), the world's largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company. At Altria, we celebrate the power of diverse teams working together to shape our future. We are inspired to bring our best because our unique strengths are valued. We believe our personal success and progress should be guided by Our Cultural Aspiration, a new articulation of what we value and who we aspire to be, collectively. Our Cultural Aspiration respects and complements individual identity, embracing each other's unique strengths, welcoming newcomers and developing the best, most inclusive and diverse teams. Join us as we work together to shape a better future for adult tobacco consumers, our employees, and our shareholders. Each Altria company is an equal opportunity employer. Learn more about Altria at www.altria.com and follow us on Twitter, Facebook and LinkedIn. *IQOS Devices and HeatSticks are currently unavailable for sale in the United States.